Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6983
Source ID: NCT02028078
Associated Drug: Insulin Human
Title: Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia
Acronym: PILOT_EGP
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 1 Diabetes Mellitus
Interventions: DRUG: Insulin human
Outcome Measures: Primary: Tracer to Tracee Ratio (the absolute relative difference ARDi ), 8 hours | Secondary: Tracer to tracee Ratio, For each subject, the mean absolute relative difference (MARD) of the tracer to tracee ratio (4% enrichment) during variable Glucose Infusion Rate from the begin of the experiment until the end of the hypoglycaemic clamp., 8 hours | Other: Time to reach each hypoglycaemic level, The stability of the tracer to tracee ratio during constant insulin infusion rate and for the different plateau levels (5.5, 3.5 and 2.5 mmol/L and for the recovery phase 4.0 mmol/L) will be investigated in an analog way., 8 hours
Sponsor/Collaborators: Sponsor: Medical University of Graz
Gender: ALL
Age: ADULT
Phases: PHASE2
Enrollment: 20
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Start Date: 2014-01
Completion Date: 2016-03
Results First Posted:
Last Update Posted: 2016-09-12
Locations: Medical University of Graz, Graz, Styria, 8036, Austria
URL: https://clinicaltrials.gov/show/NCT02028078